The global epigenetics market, valued at USD 17.21 billion in 2024, is expected to grow at a CAGR of 15.5% from 2025 to 2034, reaching USD 72.57 billion by the end of the forecast period. The market is witnessing exponential growth fueled by advances in gene regulation research, rising prevalence of cancer and chronic diseases, and the increasing adoption...